Abstract
Although colistin is frequently regarded as the antibiotic of last resort in treating carbapenem-resistant Klebsiella pneumoniae, colistin heteroresistance may in part be associated with antibiotic treatment failure. However, we do not know how widespread the colistin heteroresistance is in carbapenem-resistant K. pneumoniae isolates. In this study, we performed colistin disc diffusion assays, E-tests, and population analysis profiling for KPC-2-producing K. pneumoniae isolates to identify colistin heteroresistance. Although no colistin-resistant colonies were detected by the disc diffusion test and E-test, a colistin-resistant subpopulation was identified in population analysis profiling in all colistin-susceptible, KPC-2-producing K. pneumoniae isolates. Colistin-resistant subpopulations were also identified even when isolates had no colistin exposure. The ratio of colistin-resistant subpopulations to the total population increased as the exposure concentration of colistin increased. In in vitro time-kill assays, regrowth was observed in all isolates after 2 h upon exposure to colistin. We identified common amino acid alterations in PhoQ, PhoP, and PmrB in colistin-resistant subpopulations from some isolates, but no substitutions were found in most resistant subpopulations from other isolates. In all colistin-resistant subpopulations, overexpression of PhoQ and PbgP was observed. In this study, we demonstrated that colistin heteroresistance may be common in KPC-2-producing K. pneumoniae isolates, which could not be detected in the disc diffusion method and E-test. Colistin heteroresistance may cause colistin treatment failure in part and may evolve into resistance. Thus, development of more reliable diagnostic methods is required to detect colistin heteroresistance.
Similar content being viewed by others
References
Andersson, D.I., Nicoloff, H., and Hjort, K. 2019. Mechanisms and clinical relevance of bacterial heteroresistance. Nat. Rev. Microbiol. 17, 479–496.
Band, V.I., Satola, S.W., Burd, E.M., Farley, M.M., Jacob, J.T., and Weiss, D.S. 2018. Carbapenem-resistant Klebsiella pneumoniae exhibiting clinically undetected colistin heteroresistance leads to treatment failure in a murine model of infection. mBio 9, e02448–17.
Bardet, L., Baron, S., Leangapichart, T., Okdah, L., Diene, S.M., and Rolain, J.M. 2017. Deciphering heteroresistance to colistin in a Klebsiella pneumoniae isolate from Marseille, France. Antimicrob. Agents Chemother. 61, e00356–17.
Cheong, H.S., Kim, S.Y., Wi, Y.M., Peck, K.R., and Ko, K.S. 2019. Colistin heteroresistance in Klebsiella pneumoniae isolates and diverse mutations of PmrAB and PhoPQ in resistant subpopulations. J. Clin. Med. 8, 1444.
Choi, M.J., Kim, S.J., and Ko, K.S. 2016. Pathways regulating the pbgP operon and colistin resistance in Klebsiella pneumoniae strains. J. Microbiol. Biotechnol. 26, 1620–1628.
Clinical and Laboratory Standards Institute (CLSI). 2019. M100 Performance Standards for Antimicrobial Susceptibility Testing. 29th edn. CLSI supplement. Clinical and Laboratory Standards Institute, Wayne, Pennsylvania, USA.
Diancourt, L., Passet, V., Verhoef, J., Grimont, P.A.D., and Brisse, S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43, 4178–4182.
El-Halfawy, O.M. and Valvano, M.A. 2015. Antimicrobial heteroresistance: an emerging field in need of clarity. Clin. Microbiol. Rev. 28, 191–207.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). 2020. Breakpoint tables for interpretation of MICs and zone diameters, version 10.0. https://eucast.org/clinical_breakpoints/.
Halaby, T., Kucukkose, E., Janssen, A.B., Rogers, M.R., Doorduijn, D.J., van der Zanden, A.G., Al Naiemi, N., Vandenbroucke-Grauls, C.M., and van Schaik, W. 2016. Genomic characterization of colistin heteroresistance in Klebsiella pneumoniae during a nosocomial outbreak. Antimicrob. Agents Chemother. 60, 6837–6843.
Hong, Y.K., Kim, H., and Ko, K.S. 2020. Two types of colistin heteroresistance in Acinetobacter baumannii isolates. Emerg. Microb. Infect. 9, 2114–2123.
Kim, S.Y., Choi, H.J., and Ko, K.S. 2014. Differential expression of two-component systems, pmrAB and phoPQ, with different growth phases of Klebsiella pneumoniae in the presence or absence of colistin. Curr. Microbiol. 69, 37–41.
Kim, S.J. and Ko, K.S. 2018. Diverse genetic alterations responsible for post-exposure colistin resistance in populations of the same strain of Klebsiella pneumoniae. Int. J. Antimicrob. Agents 52, 425–429.
Landman, D., Georgescu, C., Martin, D.A., and Quale, J. 2008. Polymyxins revisited. Clin. Microbiol. Rev. 21, 449–465.
Lee, C.R., Lee, J.H., Park, K.S., Kim, Y.B., Jeong, B.C., and Lee, S.H. 2016. Global dissemination of carbapenemase-producing Klebsiella pneumoniae: epidemiology, genetic context, treatment options, and detection methods. Front. Microbiol. 7, 895.
Leung, L.M., Cooper, V.S., Rasko, D.A., Guo, Q., Pacey, M.P., McElheny, C.L., Mettus, R.T., Yoon, S.H., Goodlett, D.R., Ernst, R.K., et al. 2017. Structural modification of LPS in colistin-resistant, KPC-producing Klebsiella pneumoniae. J. Antimicrob. Chemother. 72, 3035–3042.
Li, B., Zhao, Y., Liu, C., Chen, Z., and Zhou, D. 2014. Molecular pathogenesis of Klebsiella pneumoniae. Future Microbiol. 9, 1071–1081.
Liu, Y.Y., Wang, Y., Walsh, T.R., Yi, L.X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. 2016. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161–168.
Monaco, M., Giani, T., Raffone, M., Arena, F., Garcia-Fernandez, A., Pollini, S., Network EuSCAPE-Italy, Grandmann, H., Pantosti, A., and Rossolini, G.M. 2014. Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill. 19, 20939.
Okazaki, A. and Avison, M.B. 2008. Induction of L1 and L2 β-lactamase production in Stenotrophomonas maltophilia is dependent on an AmpR-type regulator. Antimicrob. Agents Chemother. 52, 1525–1528.
Paczosa, M.K. and Mecsas, J. 2016. Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiol. Mol. Biol. Rev. 80, 629–661.
Poirel, L., Walsh, T.R., Cuvillier, V., and Nordmann, P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70, 119–123.
Rhee, J.Y., Park, Y.K., Shin, J.Y., Choi, J.Y., Lee, M.Y., Peck, K.R., Song, J.H., and Ko, K.S. 2010. KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob. Agents Chemother. 54, 2278–2279.
Shon, A.S., Bajwa, R.P., and Russo, T.A. 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4, 107–118.
Tan, K., Nguyen, J., Nguyen, K., Huse, H.K., Nieberg, P.H., and Wong-Beringer, A. 2020. Prevalence of the carbapenem-heteroresistant phenotype among ESBL-producing Escherichia coli and Klebsiella pneumoniae clinical isolates. J. Antimicrob. Chemother. 75, 1506–1512.
Weterings, V., Zhou, K., Rossen, J.W., van Stenis, D., Thewessen, E., Kluytmans, J., and Veenemans, J. 2015. An outbreak of colistin-resistant Klebsiella pneumonae in the Netherlands (July to December 2013), with inter-institutional spread. Eur. J. Clin. Microbiol. Infect. Dis. 34, 1647–1655.
Wozniak, J.E., Band, V.I., Conley, A.B., Rishishwar, L., Burd, E.M., Satola, S.W., Hardy, D.J., Tsay, R., Farley, M.M., Jacob, J.T., et al. 2019. A nationwide screen of carbapenem-resistant Klebsiella pneumoniae reveals an isolate with enhanced virulence and clinically undetected colistin heteroresistance. Antimicrob. Agents Chemother. 63, e00107–19.
Acknowledgements
This research was supported partly by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Science and ICT (grant NRF-2019R1A2C2004879), and by a 2016 grant from the Korean Society of Pediatric Infectious Diseases. The funders did not participate in study design, data collection, data analysis, decision to publish, or manuscript preparation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
We have no conflicts of interest to report.
Additional information
Supplemental material for this article may be found at http://www.springerlink.com/content/120956.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Seo, J., Wi, Y.M., Kim, J.M. et al. Detection of colistin-resistant populations prior to antibiotic exposure in KPC-2-producing Klebsiella pneumoniae clinical isolates. J Microbiol. 59, 590–597 (2021). https://doi.org/10.1007/s12275-021-0610-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12275-021-0610-1